Evidence map›Paper›PMID 17875812›Full record

ReviewJournal of leukocyte biology2008

NLR proteins: integral members of innate immunity and mediators of inflammatory diseases.

Jeanette M Wilmanski, Tanja Petnicki-Ocwieja, Koichi S Kobayashi

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of leukocyte biology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 105 papers.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

105 citing papers in PubMed, 222 citations in OpenAlex.

  1. Article
  2. An Auto-Activated NLR-Protein OsRGA3Plant biotechnology journal · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Speaking the host language: howMicrobiology (Reading, England) · 2023
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Jeanette M WilmanskiDepartment of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Dana 1420A, 44 Binney Street, Boston, MA 02115, USA.
Tanja Petnicki-Ocwieja
Koichi S Kobayashi
Harvard University · USDana-Farber Cancer Institute · US

Funding

Nod2-mediated regulation of intestinal homeostasisR01DK074738 · NIDDK · DANA-FARBER CANCER INST · PI KOBAYASHI, KOICHI S · 2007 to 2011
$1.4M
NIDDK NIH HHS DK074738-01A1NIDDK NIH HHS R01 DK074738
6 · The paper itself

Abstract

The innate immune system is the first line of defense against microorganisms and is conserved in plants and animals. The nucleotide-binding domain, leucine rich containing (NLR) protein family is a recent addition to the members of innate immunity effector molecules. These proteins are characterized by a central oligomerization domain, termed nucleotide-binding domain (NBD) and a protein interaction domain, leucine-rich repeats (LRRs) at the C terminus. It has been shown that NLR proteins are localized to the cytoplasm and recognize microbial products. To date, it is known that Nod1 and Nod2 detect bacterial cell wall components, whereas Ipaf and Naip detect bacterial flagellin, and NACHT/LRR/Pyrin 1 has been shown to detect anthrax lethal toxin. NLR proteins comprise a diverse protein family (over 20 in humans), indicating that NLRs have evolved to acquire specificity to various pathogenic microorganisms, thereby controlling host-pathogen interactions. Activation of NLR proteins results in inflammatory responses mediated by NF-kappaB, MAPK, or Caspase-1 activation, accompanied by subsequent secretion of proinflammatory cytokines. Mutations in several members of the NLR protein family have been linked to inflammatory diseases, suggesting these molecules play important roles in maintaining host-pathogen interactions and inflammatory responses. Therefore, understanding NLR signaling is important for the therapeutic intervention of various infectious and inflammatory diseases.

Indexed as

Immunity, InnateAnimalsHumansImmune System DiseasesInflammationIntracellular Signaling Peptides and ProteinsModels, ImmunologicalSignal TransductionIntracellular Signaling Peptides and Proteins

Identifiers

PMID17875812
PMCPMC3256237
OpenAlexW2111058855

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.